LABS MediPharm Labs

La farmacéutica europea STADA establece una alianza exclusiva para la distribución de cannabis medicinal con MediPharm Labs

La farmacéutica europea STADA establece una alianza exclusiva para la distribución de cannabis medicinal con MediPharm Labs
EN
08/10/2020

Underlying

LABSMediPharm Labs

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MediPharm Labs

 PRESS RELEASE
Free
LABS MEDIPHARM LABS

MediPharm Announces Voting Results from the 2025 Annual and Special Me...

MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced the results of matters voted on at its annual and special meeting (the “Meeting”) of holders of common shares ("Shareholders") held today. There were 146 Shareholders represented virtually or by proxy at the Meeting holding an aggregate of 210,726,733 common shares, representing 50...

June 17, 2025 1 EN
 PRESS RELEASE
Free
LABS MEDIPHARM LABS

MediPharm Cautions Shareholders To Await Final Results of Annual and S...

MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, wishes to respond to a misleading press release published earlier today by Apollo Technology Capital Corporation (“Apollo”) prematurely claiming that it considers the results of the annual and special meeting of shareholders scheduled to take place at 3:00 p.m. today (the “Meeting”) to be a clear victory ...

June 16, 2025 1 EN
 PRESS RELEASE
Free
LABS MEDIPHARM LABS

Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders ...

Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that leading independent proxy voting and corporate governance advisory firm Glass, Lewis & Co. LLC (“Glass Lewis”) published a report on June 12, 2025 recommending that MediPharm shareholders vote the GREEN Proxy or voting instruction form FOR the...

June 13, 2025 1 EN
 PRESS RELEASE
Free
LABS MEDIPHARM LABS

MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline

MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident’s Inadequate Plan and Nominees TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm,” the “Company,” “we” or “us”), a pharmaceutical company specialized in precision-based cannabinoids, today reminded its shareholders that the deadline is approaching to cast your vote for the upcoming Annual and Special Meeting of Shareholders on June 16, 2025 (the “Meeting”). All votes must be receive...

June 11, 2025 1 EN
 PRESS RELEASE
Free
LABS MEDIPHARM LABS

MediPharm Announces Complete Dismissal of Dissident Court Proceeding R...

MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based cannabinoids, today announced that the Superior Court of Justice – Ontario (Commercial List) (the “Court”) has fully dismissed the application (CV-25-00743454-00CL) (the “Application”) issued by Apollo Technology Capital Corporation (“Apollo”) and Nobul Technologies Inc. (together with Apollo, the...

June 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch